Discontinued — last reported Q1 '18
Natera, Inc. Allowance for Doubtful Accounts Receivable (Current) decreased by 1.1% to $7.93M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $8.02M | $7.93M |
| QoQ Change | — | -1.1% |
| Segment | Q1 '24 | Q2 '24 | Q3 '24 |
|---|---|---|---|
| Tests Delivered In Prior Periods That Were Fully Collected | $4.00M | $1.30M | $2.50M |
| Total | — | — | — |
Tests Delivered In Prior Periods That Were Fully Collected was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.